{"name":"Progyny, Inc.","slug":"progyny","ticker":"PGNY","exchange":"NASDAQ","domain":"progyny.com","description":"Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name t","hq":"New York, NY","founded":0,"employees":"835","ceo":"Pete Anevski","sector":"Healthcare Services / Fertility Benefits","stockPrice":17.34,"stockChange":0.18,"stockChangePercent":1.05,"marketCap":"$1.4B","metrics":{"revenue":1288661000,"revenueGrowth":6.7,"grossMargin":23.6,"rdSpend":9500000,"netIncome":58520000,"cash":112238000,"dividendYield":0,"peRatio":26.7,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Progyny Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Progyny reported fourth quarter and full year 2023 financial results, with revenue growth of 24% year-over-year.","drugName":"","sentiment":"positive"},{"date":"2023-11-01","type":"deal","headline":"Progyny Partners with FertilityIQ to Enhance Fertility Benefits","summary":"Progyny partnered with FertilityIQ to provide employers with a comprehensive fertility benefits platform.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9GX1FqT01HbWhvVThkY3RVZDZLVjQxMDBTRHhwV0lfV0R6eFhQYmlHNEY4Tk84MjFwVzROTTFDaTlUSHFpQXl6THgwQXFURnJVMHRwQVQxRURZbklLbmszcUZCZDFTdw?oc=5","date":"2026-04-06","type":"pipeline","source":"Stock Titan","summary":"PGNY SEC Filings - Progyny, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan","headline":"PGNY SEC Filings - Progyny, Inc. 10-K, 10-Q, 8-K Forms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBlUHMtX2lOdWxzd0hkWUUwNWZXSGw3N19DNUdVOTN4WjFSbS1CZ1FOSnhhb282M1VrRTVQWmJTVGRhUE5RdVgwSi1Wd19Ud0laNEE?oc=5","date":"2026-04-05","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Progyny, Inc. (PGNY) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Progyny, Inc. (PGNY) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1oMVNndHJHT0todTM4M0dXS0VQajZjb3VLVElCdmJZc3RlSzd0NWFpNERjSUZyaXhvT0R4SWVrdmh6M05VdUVQbERrNkFzeXdIenc?oc=5","date":"2026-04-05","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Progyny, Inc. (PGNY) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Progyny, Inc. (PGNY) stock price, news, quote and history","sentiment":"neutral"},{"date":"2026-03-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxONkl6S2Nna3RzYzVFaGJfaTdzVUdJUDRidmxLalZ1ZnRGVmE4OTlVYWVhOVIwcHk1aF95OU1RQWhkLUdabTR6LVZ6RW1sYlpBY2tIMzl2SVJxVGY3bHRwcXh0cUZDbU5kNF9McGlsb0VoLXlLaDczZ1VheHJydTQyUElTVERUd1ZYNjNmNUR1QnVsZ1B6RmFnSDFoakVJdw?oc=5","date":"2026-03-04","type":"pipeline","source":"Seeking Alpha","summary":"Progyny: Transitional Headwinds Hide An Undervalued Platform (NASDAQ:PGNY) - Seeking Alpha","headline":"Progyny: Transitional Headwinds Hide An Undervalued Platform (NASDAQ:PGNY)","sentiment":"neutral"},{"date":"2026-02-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPNmZyZXk3Yy1Pb2ZVT1o2YUoyblJhV3VVNS1uOW1EUnRVZFdtWmk1MFRSak1CR3hObjFWNWNleXRhcDlfRjNGMk9uLUhHT1I1MC1PZWoxZThOQ3RnSVo4MExVN091Ni1zY1V5Y2JmWHRxNkJQeExwYzV0TG1HZ3NPX0xfRk1GQ3FTNEFWeG1HOVZPWG9jVlJBdGM2RTZaVlZsaFk2VlZpS1FDaERiM0EyQV9pRzYzZ0plMG1uU3dn?oc=5","date":"2026-01-05","type":"pipeline","source":"AD HOC NEWS","summary":"The Truth About Progyny Inc: Is This Fertility Stock the Next Silent Millionaire Maker? - AD HOC NEWS","headline":"The Truth About Progyny Inc: Is This Fertility Stock the Next Silent Millionaire Maker?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQbi1aeFg1emRMX2p0UTU4QTk5dUI3LURxZFFUTVZIY0xiSExWbFZUa0xubjh4cS15R0Z2WUtld3BjVzJFald2RXRiTXVyZ2lUMmNIdkl1NTZGZDkxOGloX3dPUEl0LWRTbHVaRldmSFhseF8zQm93c2U3dzA0YUxuM0pTQXZhX3ZHR29rVGpQVFo0YTQ?oc=5","date":"2025-11-07","type":"pipeline","source":"TradingView","summary":"Progyny, Inc. SEC 10-Q Report - TradingView","headline":"Progyny, Inc. SEC 10-Q Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOU1ZmTjQyZnp4c3k3TEIzV25MSHpaZ21GSFFZT2g3QWwyY19icGxzeDE5MDVEeC15dkRSZzRoUlAzbUlDYW1wY0Z5UkRBRnctWjhOYlVnVmw5cjRkOHc3Rk1DTEJuTkdtUGsySE8tVWZlUFU3SDNkSHBXcldfaU16Y2YxcFpDQjdsdExxSzJQQ0hWLVE?oc=5","date":"2025-11-07","type":"pipeline","source":"GuruFocus","summary":"Decoding Progyny Inc (PGNY): A Strategic SWOT Insight - GuruFocus","headline":"Decoding Progyny Inc (PGNY): A Strategic SWOT Insight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5GVGpNQW9LYkQtVmotc1NDQjVVUk9ZWkN6WEFOTi1qcjV0ZFZVcUw5MC1qVHVmVnpzN0t5V2NlYzRTYzJmRHhraTNzOXp5V3FNNHNTQldBbnpJS1F1MXdtU3ZvYi1DU1FUM1RLM1lUVjBsWkRLNG1TMVRn?oc=5","date":"2025-08-08","type":"earnings","source":"Yahoo Finance","summary":"Progyny Inc (PGNY) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ... - Yahoo Finance","headline":"Progyny Inc (PGNY) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE9Eb0stVnVySmNiaTJpTHhYbjNxamtVOEVHZVIxVzV1WFFYMjdKSVVac214bHltaXk4ZW5lM3NGU3dmcW0zUE5EcHNidVBPYXVvbEJlaGJhWmhXSEhv?oc=5","date":"2025-07-22","type":"pipeline","source":"Finimize","summary":"Progyny Grows Fast In The Fertility Benefits Race - Finimize","headline":"Progyny Grows Fast In The Fertility Benefits Race","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPOG9zT1NGUGN5dWZ3anBOMXJlZUlwSlFoNFBZdFBKdC1jYXI0Q1BNZGVoV0dOYlRfVU1RcWkxakJ2MTd1cVR1S1ZLbVR2QlpjRjVhcVV6VG1OWVdkRW1mM3VBa01QdWFNWnFHUnQ2a2dHbV9XLXJNTzJOaXZiWkhBWU1weEJRYTd2ZTVxQTJ6YUJSTUR0U2szbFc4bEJGRjFDdVZQbmFB?oc=5","date":"2025-05-28","type":"pipeline","source":"Seeking Alpha","summary":"Progyny Stock: Robust Expectations In 2025 Amid Growing Expenses (Hold) (NASDAQ:PGNY) - Seeking Alpha","headline":"Progyny Stock: Robust Expectations In 2025 Amid Growing Expenses (Hold) (NASDAQ:PGNY)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQNE43bU9HMnYxWk9yemh6WW5kMWxlN2s0LXE0X0p0VHRZUGZIaGNGU3pnN2duZ1RWcFRPalJXX1Mxa29SV1p3UmtZZkJjZGhVc2hJTmVXZlA3Zlo1UWNHQjdabkRIeWtSTlVNMjd2ZG9MOWJ0LUR3QUcxTXVKUmswdE5vbUFEOGRGQXpUaVpwLVpVeFpPZ3k4eUUxdGdvZkpZb0tiZkZsVGF3Rjk0a2I4Qnd0RkMydTBleDV5YzRJcm1GMnlsZ2hXRGNCNXRfTzVqa1hfWlN0RE1GQQ?oc=5","date":"2025-01-13","type":"pipeline","source":"PR Newswire","summary":"Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services - PR Newswire","headline":"Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Ferring Pharmaceuticals","Ivax Corporation","EMD Serono"],"therapeuticFocus":["Fertility Benefits"],"financials":{"source":"sec_edgar","revenue":1288661000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":1288661000,"period":"2025-12-31"},{"value":313346000,"period":"2025-09-30"},{"value":332874000,"period":"2025-06-30"},{"value":324038000,"period":"2025-03-31"},{"value":1167221000,"period":"2024-12-31"},{"value":286625000,"period":"2024-09-30"}],"grossProfit":304484000,"grossProfitHistory":[],"rdSpend":9500000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":58520000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":112238000,"cashHistory":[],"totalAssets":742435000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":17.34,"previousClose":17.16,"fiftyTwoWeekHigh":28.75,"fiftyTwoWeekLow":16.28,"fiftyTwoWeekRange":"16.28 - 28.75","fiftyDayAverage":19.87,"twoHundredDayAverage":22.28,"beta":0.99,"enterpriseValue":1123072256,"forwardPE":8.3,"priceToBook":2.78,"priceToSales":1.1,"enterpriseToRevenue":0.87,"enterpriseToEbitda":11.47,"pegRatio":0,"ebitda":97925000,"ebitdaMargin":7.6,"freeCashflow":212500624,"operatingCashflow":210192000,"totalDebt":27726000,"debtToEquity":5.4,"currentRatio":2.73,"returnOnAssets":8.6,"returnOnEquity":12.5,"analystRating":"","recommendationKey":"none","numberOfAnalysts":11,"targetMeanPrice":27.45,"targetHighPrice":31,"targetLowPrice":19,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":1.8,"institutionHeldPercent":107.8,"sharesOutstanding":81902232,"floatShares":74936447,"sharesShort":5634108,"shortRatio":2.99,"shortPercentOfFloat":6.9,"epsTrailing":0.65,"epsForward":2.1,"revenuePerShare":15.04,"bookValue":6.24,"officers":[{"age":66,"name":"Mr. David J. Schlanger J.D.","title":"Executive Chairman"},{"age":58,"name":"Mr. Peter  Anevski CPA","title":"CEO & Director"},{"age":59,"name":"Mr. Mark S. Livingston CPA","title":"Chief Financial Officer"},{"age":35,"name":"Ms. Allison  Swartz","title":"Executive VP, General Counsel & Secretary"},{"age":null,"name":"Ms. Melissa B. Cummings","title":"Chief Operating Officer"},{"age":null,"name":"Mr. Steven  Leist","title":"Chief Technology Officer"},{"age":null,"name":"Mr. James  Hart","title":"Vice President of Investor Relations"},{"age":null,"name":"Ms. Risa  Fisher","title":"Chief Marketing Officer"}],"industry":"Healthcare Plans","irWebsite":"","website":"https://www.progyny.com","phone":"212 888 3124"}}